Table 1 Patient and tumour characteristics and their corresponding n values.

From: Characterising 18F-fluciclovine uptake in breast cancer through the use of dynamic PET/CT imaging

Characteristic

n (%)

Recruited patients

39 (100)

Tumour histology

 IDC

39 (100)

Tumour grade

 1

7 (18)

 2

12 (31)

 3

20 (51)

Receptor subtype

 ER+ HER2−

24 (61.5)

 HER2+

8 (20.5)

 TN

7 (18)

On metformin

 No

35 (90)

 Yes

4 (10)

Tumour diameter (mm)

 

Median (range)

24 (15–70)